纳指生物科技ETF(513290)
动态评分: 5.70分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2024-06-30 | AVXL | Anavex Life Sciences Corp | 29.9 | 0.04% |
2024-06-30 | CABA | Cabaletta Bio Inc | 30.23 | 0.04% |
2024-06-30 | ACIU | AC Immune SA | 33.05 | 0.04% |
2024-06-30 | FULC | Fulcrum Therapeutics Inc | 32.26 | 0.04% |
2024-06-30 | PGEN | Precigen Inc | 33.39 | 0.04% |
2024-06-30 | VERV | Verve Therapeutics Inc | 34.31 | 0.04% |
2024-06-30 | PACB | Pacific Biosciences of California Inc | 31.24 | 0.04% |
2024-06-30 | PAHC | 美国辉宝 | 28.56 | 0.04% |
2024-06-30 | EDIT | Editas Medicine Inc | 32.15 | 0.04% |
2024-06-30 | TBPH | Theravance Biopharma Inc | 34.53 | 0.04% |
2024-06-30 | LYEL | Lyell Immunopharma Inc | 30.95 | 0.04% |
2024-06-30 | GRAL | GRAIL Inc | 34.15 | 0.04% |
2024-06-30 | VYGR | Voyager Therapeutics Inc | 36.03 | 0.04% |
2024-06-30 | MXCT | MaxCyte Inc | 34.31 | 0.04% |
2024-06-30 | MGNX | MacroGenics Inc | 22.28 | 0.03% |
2024-06-30 | AVIR | Atea Pharmaceuticals Inc | 23.34 | 0.03% |
2024-06-30 | VNDA | Vanda Pharmaceuticals Inc | 27.53 | 0.03% |
2024-06-30 | EXAI | Exscientia plc ADR | 20.92 | 0.03% |
2024-06-30 | XERS | Xeris制药 | 27.93 | 0.03% |
2024-06-30 | AMRN | 阿玛琳 | 23.03 | 0.03% |
公告&资料
